WILLS EYE IS HIRING – CLICK HERE TO APPLY TODAY!

Clinical Trials Enrollment Ocular Oncology

RESEARCH_Secondary Page Header
Age Related Macular Degeneration
RESEARCH
Advancing Science • Fostering Collaboration • Inspiring Innovation
Age Related Macular Degeneration

Wills Eye Ocular Oncology Studies

 

Aura Nanoparticle Therapy in the Management of Choroidal Melanoma and Metastasis
Wills Eye Study Doctors: Carol L. Shields, MD and Sara E. Lally, MD

Potential of Aqueous Humor for Uveal Melanoma
Wills Eye Study Doctors: Carol L. Shields, MD and Sara E. Lally, MD

Potential of Aqueous Humor for Retinoblastoma
Wills Eye Study Doctors: Carol L. Shields, MD and Sara E. Lally, MD

A Randomized Clinical Trial Evaluating Anti-VEGF vs. Sustained-Release Corticosteroid vs. Observation for Prevention of Visual Acuity Loss due to Radiation Retinopathy
Wills Eye Study Doctors: Carol L. Shields, MD and Sara E. Lally, MD

Phase II Randomized Trial of Radiotherapy Followed by Intravitreal Aflibercept Injection for Patients with Ocular Melanoma
Wills Eye Study Doctors: Carol L. Shields, MD and Sara E. Lally, MD

To learn more about the studies listed above, please contact:

Lisa Cotelesa
Ocular Oncology Study Coordinator
Email: lisac@shields.md
Phone: (215) 928-3108